WIRED @WIRED
Antibody drugs have kept high-risk patients out of the hospital. Over the past two years, the FDA authorized a handful of them for the treatment of mild to moderate Covid-19, but one by one, all of them faltered as the virus mutated. https://t.co/wDY3XJVwbT — PolitiTweet.org